Aruk Pharma Limited Liability Partnership - Company Profile

It is a healthcare limited liability partnership based in Hubli, Karnataka, India, established in 2020.
2020 Hubli, Karnataka, India Active
Last Updated:
About Aruk Pharma Limited Liability Partnership

Aruk Pharma Limited Liability Partnership, a active limited liability partnership, was established on 12 July 2020 in Hubli, Karnataka, India. Engaging in health and social work within the healthcare sector, it holds LLPIN: AAS-8573. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Sanjeev Bhavikatti (Designated Partner), Sukanya Sanjeev Bhavikatti (Designated Partner). Its latest date of accounts and solvency statement 31 March 2022. It is based at C/O Plot No 3D, Behind Rambhapuri, Kalyan Mantap, Kalyan Nagar, 213 213 Vid, Ya Nagar,, Hubli, Karnataka, 580030.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAS-8573

  • Incorporation Date

    12 July 2020

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 6 Months
  • Last Filing with ROC 31 Mar 2022
Company report

Aruk Pharma Limited Liability Partnership

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aruk Pharma Limited Liability Partnership — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aruk Pharma Limited Liability Partnership?
Current Designated Partners
Name Designation Appointment Date Status
Sanjeev Bhavikatti Designated Partner 12 Jul 2020 Current
Sukanya Sanjeev Bhavikatti Designated Partner 23 Dec 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aruk PharmaLiability Partnership.

Enhance accessibility to Aruk PharmaLiability Partnership's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aruk PharmaLiability Partnership revenue growth over time
Aruk PharmaLiability Partnership profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aruk PharmaLiability Partnership?

Unlock access to Aruk PharmaLiability Partnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aruk PharmaLiability Partnership?

Unlock and access historical data on people associated with Aruk PharmaLiability Partnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aruk PharmaLiability Partnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aruk PharmaLiability Partnership's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aruk PharmaLiability Partnership
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aruk Pharma Limited Liability Partnership last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Aruk Pharma Limited Liability Partnership has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was documented.

  • Director Appointment

    Sukanya Sanjeev Bhavikatti was appointed as a Designated Partner was appointed as a Designated Partner on 23 Dec 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Sanjeev Bhavikatti was appointed as a Designated Partner was appointed as a Designated Partner on 12 Jul 2020 & has been associated with this company since 5 years 6 months . was completed.

  • LLP Incorporation

    The activity Aruk Pharma Limited Liability Partnership was registered on 12 Jul 2020 with Roc Bangalore & aged 5 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aruk Pharma Limited Liability Partnership?

The LLPIN of Aruk Pharma Limited Liability Partnership is AAS-8573.

Where is Aruk Pharma Limited Liability Partnership headquartered?

Aruk Pharma Limited Liability Partnership is headquartered at C/O Plot No 3D, Behind Rambhapuri, Kalyan Mantap, Kalyan Nagar, 213 213 Vid, Ya Nagar,, Hubli, Karnataka, 580030.

When was Aruk Pharma Limited Liability Partnership incorporated?

Aruk Pharma Limited Liability Partnership was incorporated on 12 July 2020.

Who are the current directors of Aruk Pharma Limited Liability Partnership?

The current directors of Aruk Pharma Limited Liability Partnership are

What is the primary industry of Aruk Pharma Limited Liability Partnership?

The primary industry of Aruk Pharma Limited Liability Partnership is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available